Bridgeway Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $126K | Buy |
|
|||||
|
2025
Q2 | $28K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1.97M | Sell |
|
|||||
|
2017
Q4 | $1.56M | Hold |
|
|||||
|
2017
Q3 | $1.01M | Buy |
|
|||||
|
2017
Q2 | $810K | Hold |
|
|||||
|
2017
Q1 | $1.14M | Hold |
|
|||||
|
2016
Q4 | $628K | Hold |
|
|||||
|
2016
Q3 | $780K | Sell |
|
|||||
|
2016
Q2 | $671K | Sell |
|
|||||
|
2016
Q1 | $854K | Buy |
|
|||||
|
2015
Q4 | $757K | Buy |
|
|||||
|
2015
Q3 | $503K | Buy |
|
|||||
|
2015
Q2 | $239K | Buy |
|